A cost-effectiveness analysis of DA-EPOCH-R versus R-CHOP for the treatment of diffuse large B-cell lymphoma.

Ashni Gokul,Maria Boyce,Deirdre OMahony,Brian Richard Bird

A cost-effectiveness analysis of DA-EPOCH-R versus R-CHOP for the treatment of diffuse large B-cell lymphoma.

2017

Ashni Gokul
Maria Boyce
Deirdre OMahony
Brian Richard Bird

e19018Background: Clinical trials have indicated that dose adjusted etoposide, prednisolone, vincristine, cyclophosphamide, doxorubicin and rituximab (DA-EPOCH-R) may improve clinical outcomes when...

Keywords:

Diffuse large B-cell lymphoma
Pathology
Cost-effectiveness analysis
Cancer research
CHOP
Medicine
Prednisolone
Oncology
Clinical trial
Rituximab
Doxorubicin
Internal medicine
Etoposide
Cyclophosphamide
Vincristine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations